Search research articles
Contact Us
Filters
Showing results (21-30 of 62) with videos related to
Page
of 7
Sort By:
Nature Cancer
|
December 15, 2023
Breaking the performance ceiling for neoantigen immunogenicity prediction
Hugh O'Brien, Max Salm, Laura T Morton, et al.
Leukemia
|
June 29, 2021
Prognostic value of Oncogenetic mutations in pediatric T Acute Lymphoblastic Leukemia: a comparison of UKALL2003 and FRALLE2000T protocols
Mary M Taj, Anthony V Moorman, Lina Hamadeh, et al.
Gastroenterology
|
July 8, 2014
Ribonucleoprotein HNRNPA2B1 interacts with and regulates oncogenic KRAS in pancreatic ductal adenocarcinoma cells
Carles Barceló, Julia Etchin, Marc R Mansour, et al.
British Journal of Haematology
|
June 26, 2020
Successful remission induction therapy with gilteritinib in a patient with de novo FLT3-mutated acute myeloid leukaemia and severe COVID-19
Andrew J Wilson, Ethan Troy-Barnes, Maryam Subhan, et al.
Leukemia & Lymphoma
|
December 4, 2020
Utility of 18F-FDG-PET/CT in lymphoblastic lymphoma
Thomas A Fox, Ben Carpenter, Mary Taj, et al.
Haematologica
|
March 10, 2018
Prognostic impact of the absence of biallelic deletion at the <i>TRG</i> locus for pediatric patients with T-cell acute lymphoblastic leukemia treated on the Medical Research Council UK Acute Lymphoblastic Leukemia 2003 trial
Nadine Farah, Amy A Kirkwood, Sunniyat Rahman, et al.
Elife
|
May 1, 2016
Synergy between loss of NF1 and overexpression of MYCN in neuroblastoma is mediated by the GAP-related domain
Shuning He, Marc R Mansour, Mark W Zimmerman, et al.
The Journal of Experimental Medicine
|
July 17, 2013
The TAL1 complex targets the FBXW7 tumor suppressor by activating miR-223 in human T cell acute lymphoblastic leukemia
Marc R Mansour, Takaomi Sanda, Lee N Lawton, et al.
British Journal of Haematology
|
February 5, 2013
KPT-330 inhibitor of CRM1 (XPO1)-mediated nuclear export has selective anti-leukaemic activity in preclinical models of T-cell acute lymphoblastic leukaemia and acute myeloid leukaemia
Julia Etchin, Takaomi Sanda, Marc R Mansour, et al.
Plos Computational Biology
|
November 11, 2024
A modular protein language modelling approach to immunogenicity prediction
Hugh O'Brien, Max Salm, Laura T Morton, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 62) with videos related to
Sort By:
Page
of 7
Nature Cancer
|
December 15, 2023
Breaking the performance ceiling for neoantigen immunogenicity prediction
Hugh O'Brien, Max Salm, Laura T Morton, et al.
Leukemia
|
June 29, 2021
Prognostic value of Oncogenetic mutations in pediatric T Acute Lymphoblastic Leukemia: a comparison of UKALL2003 and FRALLE2000T protocols
Mary M Taj, Anthony V Moorman, Lina Hamadeh, et al.
Gastroenterology
|
July 8, 2014
Ribonucleoprotein HNRNPA2B1 interacts with and regulates oncogenic KRAS in pancreatic ductal adenocarcinoma cells
Carles Barceló, Julia Etchin, Marc R Mansour, et al.
British Journal of Haematology
|
June 26, 2020
Successful remission induction therapy with gilteritinib in a patient with de novo FLT3-mutated acute myeloid leukaemia and severe COVID-19
Andrew J Wilson, Ethan Troy-Barnes, Maryam Subhan, et al.
Leukemia & Lymphoma
|
December 4, 2020
Utility of 18F-FDG-PET/CT in lymphoblastic lymphoma
Thomas A Fox, Ben Carpenter, Mary Taj, et al.
Haematologica
|
March 10, 2018
Prognostic impact of the absence of biallelic deletion at the <i>TRG</i> locus for pediatric patients with T-cell acute lymphoblastic leukemia treated on the Medical Research Council UK Acute Lymphoblastic Leukemia 2003 trial
Nadine Farah, Amy A Kirkwood, Sunniyat Rahman, et al.
Elife
|
May 1, 2016
Synergy between loss of NF1 and overexpression of MYCN in neuroblastoma is mediated by the GAP-related domain
Shuning He, Marc R Mansour, Mark W Zimmerman, et al.
The Journal of Experimental Medicine
|
July 17, 2013
The TAL1 complex targets the FBXW7 tumor suppressor by activating miR-223 in human T cell acute lymphoblastic leukemia
Marc R Mansour, Takaomi Sanda, Lee N Lawton, et al.
British Journal of Haematology
|
February 5, 2013
KPT-330 inhibitor of CRM1 (XPO1)-mediated nuclear export has selective anti-leukaemic activity in preclinical models of T-cell acute lymphoblastic leukaemia and acute myeloid leukaemia
Julia Etchin, Takaomi Sanda, Marc R Mansour, et al.
Plos Computational Biology
|
November 11, 2024
A modular protein language modelling approach to immunogenicity prediction
Hugh O'Brien, Max Salm, Laura T Morton, et al.
Page
of 7